MamaMancini's delivered a robust Q3 2026 top-line, with revenue of $47.27 million, up 49.95% year over year and 34.28% quarter over quarter, supported by expanded distribution reach and favorable product mix. Gross profit rose to $11.14 million, producing a gross margin of 23.56%, while EBITDA stood at $0.823 million and net income was $0.54 million (EPS $0.01). The year-over-year improvement in revenue and earnings occurred alongside a notable increase in SG&A costs, as evidenced by selling, general, and administrative expenses of $10.23 million in the quarter, compared with $7.02 million in the prior quarter. This SG&A expansion contributed to a moderated operating margin (about 1.74% of revenue) despite positive operating leverage on a gross basis.
From a cash-flow perspective, operating cash flow was $3.87 million in the quarter, with free cash flow of $3.67 million. The company deployed cash to fund acquisitions (AcquisitionsNet of approximately $17.5 million) and simultaneously issued common stock (~$18.93 million) to support strategic initiatives, yielding a net cash inflow from financing activities of $22.51 million and a net increase in cash of $8.68 million. The balance sheet remains liquidity rich: cash and cash equivalents of $18.07 million, total assets of $84.03 million, and net debt of negative $9.78 million, reflecting a net cash position. Management commentary (where available) focused on continued distribution expansion and product acceptance, while signaling a disciplined approach to leveraging acquisitions to drive scale. Investors should monitor margin progression, integration of acquisitions, and the sustainability of top-line growth against input cost volatility and promotional activity.